What appears inside the room as incremental progress accumulates outside it as measurable cost.
In 2019, Medicaid spent about $660 million nationwide on autism therapy; by 2023, that figure had reached roughly $2.2 billion, transforming a once-specialized treatment field into a large and rapidly expanding industry.¹ The growth reflects something real, because diagnoses have increased steadily, with federal estimates placing roughly one in 31 American children somewhere on the spectrum, and families searching for help are not imagining the need.¹
Inside clinics, progress remains granular—a word spoken clearly, a task completed without prompting, a gesture repeated until it holds—while outside clinics the same hour converts directly into a claim, processed, reimbursed, and folded into a system that treats time as both care and commodity.
Medicaid pays providers through hourly reimbursement, and once a clinic is approved each hour delivered becomes billable, supported by a funding structure in which the federal government often covers about 70 percent of the cost.² That combination—hourly billing paired with a guaranteed payer—creates conditions where expansion follows a predictable path rather than a speculative one.
Markets do not need to be invented under those conditions. They emerge as clinics open in office parks and converted storefronts, as investors recognize the reliability of government-backed payment, and as hiring accelerates for technicians who deliver the sessions that generate the billable hours, even when those technicians remain near the bottom of the wage scale.
In Indiana, one company—Piece by Piece Autism Centers—illustrates how far that structure can extend once it begins scaling. Founded in 2019 by Meghann Mitchell, a former gymnastics coach who became a behavior analyst, the company followed a model that separates design from delivery: licensed analysts create treatment plans, while registered technicians conduct the sessions that fill the schedule.³
Those technicians typically earned under twenty dollars an hour, while the hours they produced were valued far higher within the reimbursement system, and the gap between labor cost and billable output widened as pricing moved.
When the company began, therapy was priced at about $200 per hour; by late 2023, the listed rate had climbed to roughly $1,600 per hour, with Medicaid reimbursing about 40 percent—around $640 for each hour delivered.⁴ Multiply that across dozens of patients and full weekly schedules, and the totals begin to accelerate in ways that are difficult to reconcile with the simplicity of the room where the work occurs.
In 2023, Indiana Medicaid paid the company $29 million to treat 84 children—about $340,000 per patient—and over five years total payments reached roughly $58 million.³⁵ Mitchell said the company complied with billing rules and passed multiple audits without findings of fraud, and when asked what justified the pricing increases she pointed not to a single cost driver but to decisions made alongside a business partner.⁴
The answer does not sit with the company alone, because the structure that allows it does not originate there.
Autism therapy operates in a part of healthcare that lacks a universal national standard for how many hours a child should receive, leaving treatment plans to be adjusted by clinicians over time, which helps families but removes a natural ceiling on expansion.